Skip to content

My Team of Care: a Pilot Randomized Controlled Trial of an Online Communication Tool for Collaborative Care

My Team of Care (MyTOC) Trial: a Pilot Randomized Controlled Trial of an Online Communication Tool (Loop) for Collaborative Care in Complex Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02372994
Acronym
Loop
Enrollment
49
Registered
2015-02-26
Start date
2015-01-31
Completion date
2016-04-30
Last updated
2016-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communication, Neoplasms

Keywords

chronic disease, continuity of patient care, patient engagement, cost effectiveness analysis, user-centred design, Interdisciplinary Health Team, Medical Informatics, Patient-centred care

Brief summary

This project will pilot and test a new online communication tool, Loop, developed within a research framework with participatory and user-centred design. This pilot trial focuses on advanced cancer as an example of complex care. Cancer care involves many healthcare providers, spanning hospital to home. There is no organized way for them to communicate. Loop is a practical tool for ongoing collaboration in the patient's actual team of care that engages patients. The study will answer the questions: does Loop improve communication efficiency, engage patients and family physicians, and show early benefits in quality and health care costs?

Interventions

OTHERLoop

Loop is a secure online communication system centered on the patient that assembles the patient's actual healthcare team for ongoing collaborative care. The patient and caregiver are integral members of the team. Loop is cross-organizational, cross-setting and interprofessional. It is for ongoing, interactive, contextual, team-based communication. Loop is explicitly for asynchronous communication, not instant messaging. The stream of messages is stored and can be sorted for ease of viewing. The tool was developed with user-centred design and requires no prior training.

Sponsors

Mount Sinai Hospital, Canada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Patients with Stage IV cancer, or Patients with stage III cancer and poor prognosis as determined by a physician (\>3 months but \<2 years) 2. Eastern Cooperative Oncology Group (ECOG) performance status score ≤2 3. Each patient must have at least two healthcare providers, including an attending oncologist or palliative care physician 4. Patient and, if applicable, family caregiver must be ≥18 years of age 5. Literacy and language capacity and competency to provide informed consent 6. Patient or caregiver must have access to a computer and the internet

Exclusion criteria

1. Patients without the capacity to participate in use of the online tool, and do not have a caregiver who can engage in use of the tool on their behalf 2. Participants without the capacity to participate in evaluation of outcome measures, including, but not limited to, online and paper-based multiple-choice questions, checklists, and visual analogue scales, and do not have a family caregiver who can complete outcome measures 3. A potential candidate for or currently receiving hormone therapy for breast or prostate cancer 4. Patients with a prognosis of \<3 months as determined by attending physician 5. Patients with impaired mental status as previously assessed by a physician or judged by research staff using the Bedside Confusion Scale 6. It has been determined that the patient is participating in another study precluding them from taking part in this study, as determined by an agreed-upon algorithm, tracked and managed by study coordinators

Design outcomes

Primary

MeasureTime frame
Trial feasibility measured with number of patients recruited for study who have consented and participate for the duration of the study.1 year

Secondary

MeasureTime frameDescription
Eastern Cooperative Oncology Group score3 monthsA measure of performance status
Instrument completion rate for the Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale1 year
Item response rate for the Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale1 year
Instrument completion rate for the Ambulatory and Home Care Record1 year
Item response rate for the Ambulatory and Home Care Record1 year
Instrument completion rate for the Edmonton Symptom Assessment Scale1 year
Item response rate for the Edmonton Symptom Assessment Scale1 year
Number of family physicians who participate per study group1 year
Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale3 monthsAn 8 item questionnaire measuring patient-perceived continuity and coordination of care
Trial feasibility measured with number of healthcare providers recruited for study who have consented and participate for the duration of the study.1 year
Trial feasibility measured with number of family caregivers recruited for study who have consented and participate for the duration of the study.1 year
Palliative Care Outcomes Scale3 monthsA 12 item questionnaire measuring patient-reported quality of care
Ambulatory and Home Care Record3 monthsMeasure of ambulatory, home-based and acute care health services utilization, and associated public and private costs
Edmonton Symptom Assessment Scale3 monthsA 10 item questionnaire measuring symptom intensity
The proportion of eligible participants who are invited to participate1 year
The proportion of invited participants who consent to participate1 year
The mean duration of participation of all study participants1 year
Instrument completion rate for the Palliative Care Outcomes Scale1 year
Item response rate for the Palliative Care Outcomes Scale1 year

Other

MeasureTime frameDescription
Number of times a caregiver logs into the Loop system3 months
Number of times a healthcare provider logs into the Loop systemAt end of study participationHealthcare providers will be enrolled in the study for between 3 months and 1 year
Time interval between a message posting by a patient/caregiver and a response by a healthcare provider on the Loop system3 months
Number of occurrences of user-reported errors3 months
Proportion of functions being used on the Loop system3 months
Number of posts per participant on the Loop system3 months
Number of times a patient logs into the Loop system3 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026